PAZOPANIB-TEVA FC TABLETS 200 MG
Product details
Registration number: SIN17000P
Classification: Prescription Only
Active ingredients: Pazopanib hydrochloride eqv Pazopanib
Strength: 200 mg
Dosage form: TABLET, FILM COATED
Route: ORAL
Registrant: TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
ATC code: L01XE11
HSA approval date: 8 May 2024
Manufacturer(s): PharOS MT Ltd
Manufacturing country/countries: MALTA
What are the HSA registration number and classification for PAZOPANIB-TEVA FC TABLETS 200 MG?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN17000P
Classification: Prescription Only
What active ingredients and strength are recorded for PAZOPANIB-TEVA FC TABLETS 200 MG?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Pazopanib hydrochloride eqv Pazopanib
Strength: 200 mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for PAZOPANIB-TEVA FC TABLETS 200 MG?
According to the HSA dataset updated 7 August 2026:
Dosage form: TABLET, FILM COATED
Route: ORAL
Who is the recorded registrant for PAZOPANIB-TEVA FC TABLETS 200 MG?
According to the HSA dataset updated 7 August 2026:
Registrant: TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for PAZOPANIB-TEVA FC TABLETS 200 MG?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): PharOS MT Ltd
Manufacturing country/countries: MALTA
Where can I look up PAZOPANIB-TEVA FC TABLETS 200 MG in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN17000P or the exact product name PAZOPANIB-TEVA FC TABLETS 200 MG. The general register link does not preselect this product.
What are the source dates for this PAZOPANIB-TEVA FC TABLETS 200 MG record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this PAZOPANIB-TEVA FC TABLETS 200 MG record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN17000P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)